Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Pain|March 17, 2017
The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraineSmriti Iyengar, Michael H Ossipov, Kirk W JohnsonCurrent Pharmaceutical Design|April 14, 2004
Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetesAllan S Wagman, Kirk W Johnson, Dirksen E BussiereHeadache|April 16, 2019
CGRP and the Trigeminal System in MigraineSmriti Iyengar, Kirk W Johnson, Michael H Ossipov, et al.Neuroscience Letters|June 15, 2005
Systemic administration of propentofylline does not attenuate morphine tolerance in non-injured rodentsJennifer A Shumilla, Isa Samuels, Kirk W Johnson, et al.European Journal of Pharmacology|April 20, 2010
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapsePatrick M Beardsley, Keith L Shelton, Elizabeth Hendrick, et al.Expert Opinion on Investigational Drugs|June 28, 2007
Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromesAnnemarie Ledeboer, Mark R Hutchinson, Linda R Watkins, et al.Headache|July 21, 2025
Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgiasMarta Vila-Pueyo, Peter J Goadsby, Kirk W Johnson, et al.Cephalalgia : an International Journal of Headache|April 21, 2019
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [<sup>125</sup>I] galcanezumab in male ratsKirk W Johnson, S Michelle Morin, Victor J Wroblewski, et al.Journal of Psychiatric Research|August 27, 2021
Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medicationsBrianne Redman, Chris Kitchen, Kirk W Johnson, et al.Headache|July 13, 2022
Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonistsKirk W Johnson, Xia Li, Xiaofang Huang, et al.Pageof 7